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Cutting the research pie: a value-weighting approach to explore perceptions about psychosocial research
priorities for adults with haematological cancers
Despitetheburdenofillnessassociatedwithhaematologicalcancers,littleresearchisavailableaboutimproving
psychosocial outcomes for this group. Given scarce research funds, it is important to ensure that resources are
used strategically for improving their psychosocial well-being. This study aimed to identify the perceptions of
professionals, patients and carers regarding prioritising psychosocial research efforts. First, an expert panel’s
views on priorities for research were identiﬁed. This was followed by a web survey to obtain the perceptions of
117 health professionals, patients and carers. The value-weighting survey used points allocation, allowing
respondents to indicate the relative priority of each option. A substantial proportion of resources were allocated
topatientswhowerenewlydiagnosedorreceivingtreatment.Lessprioritywasgiventootherstagesofthecancer
journey or non-patient populations. There was no indication that any type of psychosocial research was a
priority; however, some differences were identiﬁed when comparing the priorities of the three respondent
groups. To improve psychosocial outcomes for haematological cancer patients, resources should be directed
towards patients in the early stages of the cancer journey. There may be a need for research investigating
potential interventions to improve psychosocial outcomes for patients with haematological cancers.
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Haematological cancers are associated with a high
burden of illness
As treatment outcomes improve and the population ages,
haematological cancers such as lymphoma, leukaemia
and myeloma represent a growing cancer survivor popu-
lation (Australian Institute of Health and Welfare (AIHW)
& the Australasian Association of Cancer Registries
(AACR) 2008). In countries such as Australia, haemato-
logical cancers such as lymphoma and leukaemia repre-
sent the 6th and 8th most common cancers (Australian
Institute of Health and Welfare (AIHW) & the Australa-
sian Association of Cancer Registries (AACR) 2008).
However, survival is relatively poor (Australian Institute
of Health and Welfare (AIHW) & the Australasian Asso-
ciation of Cancer Registries (AACR) 2008), and treatments
for these cancers can result in a range of debilitating side
effects (Richardson et al. 1988).
The importance of psychosocial health for people with
haematological cancers
Rates of clinical distress have been reported to range
between 32% and 48% for haematological patients
(Carlson et al. 2004). Treatment can have a devastating
impact on the lives of those diagnosed and treated, affect-
ing fertility, sexuality (Schover 2005) and the ability to
fulﬁl usual vocational, social and family roles (Sherman
et al. 2005). Despite this, psychosocial issues among
people with haematological cancers and their support
persons remain relatively unstudied compared with survi-
vors of other common types of cancer such as breast,
prostate and colorectal cancers (Macvean et al. 2007).
A need for targeted research into improving
psychosocial health
A range of supportive interventions including screening
for psychosocial symptoms have been trialled with some
cancer survivor groups with limited success (McLachlan
et al. 2001; Aranda et al. 2006; Boyes et al. 2006). While
research suggests such interventions may help, the evi-
dence base regarding how to improve psychosocial out-
comes for cancer survivors is in its infancy (Aziz 2007).
Funds available for such research are also quite limited.
Adult haematological cancers in particular may attract
relatively little funding due to a lower community proﬁle
than other groups. Short survival times (Australian Insti-
tute of Health and Welfare (AIHW) & the Australasian
Association of Cancer Registries (AACR) 2008) also limit
the opportunities for rigorous intervention studies with
this group. Consequently, it is important that the avail-
able research resources are used strategically to address
key issues.
Both researchers who choose the focus of their research
efforts and those involved in making decisions about stra-
tegic directions for research funding would beneﬁt from
an understanding of what kinds of psychosocial research
are most needed. Research with other cancer groups
(Grassi & Rosti 1996; Devine 2003; Hodgkinson et al.
2007) suggests it is important to consider which popula-
tions should be the focus of research as well as the
research topic or type. Populations that should be consid-
ered include patients at various stages of survivorship and
non-patient groups such as partners or carers. Psychoso-
cial research topics may range from the consideration of
measurement issues (Thewes et al. 2004), to evaluation of
speciﬁc therapies (Marcus et al. 1998) or changes in the
treatment environment (Mills et al. 2009).
Who should make decisions about where to target
research funding?
In the absence of data, the ﬁrst step in devising a strategic
psychosocial research agenda is to seek the views of a wide
range of relevant ‘experts’ about which research is most
needed to deliver the greatest beneﬁt. The term ‘expert’
should not be limited to those with the highest level of
clinical expertise or those able to allocate funding. The
growing emphasis on consumer involvement in decision
making (Fink et al. 1984; Oliver et al. 2004) and a multi-
disciplinary approach to cancer care (Ko & Chaudry 2002)
necessitates recognition that each group is an expert in its
own area of endeavour. Therefore, deciding on a strategic
research agenda for improving psychosocial outcomes
should involve patients, their carers, clinicians, research-
ers, social workers, psychologists and patient advocates.
While the views of these various experts may not always
agree, each perspective is valid.
What method should be used to make decisions about
psychosocial research priorities regarding
haematological cancers?
Any funding agency with limited resources has to make a
decision about where to spend its money. There are a
range of methods for determining research priorities
including advocacy-based decision-making approaches
that take into consideration the views of individuals or
small groups of experts or stakeholders who advocate for
research in a particular area (Chalkidou et al. 2009). In
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process do not rely on individual stakeholder perceptions
alone, but rather aim to determine the level of agreement
between stakeholders (Beretta 1996). Funding decisions
require some sense of the perceived relative value of the
options. Concepts from the ﬁeld of health economics such
as ‘willingness to pay’ and techniques such as the ‘stan-
dard gamble’ (Shiell et al. 2002) can assist with this need.
However, these techniques often place a high demand on
the respondent if the relative value of a large range of
options must be determined. An alternative approach is to
provide experts with a scenario similar to that faced by
decision makers – what proportion of funding should be
directed towards each of the available research options?
An alternative method for obtaining perceived
research priorities
One such method is the two-step value-weighting
approach, which is designed to capture breadth and differ-
ence of opinion in a cost- and time-efﬁcient manner,
increasing the likelihood of its being regularly used. The
ﬁrst step involves using a modiﬁed Delphi approach to
develop a list of potential priority research items. Just as
the Delphi method recognises the importance of collect-
ing and distilling the knowledge of experts (Adler & Ziglio
1996), the value-weighting approach assumes that the col-
lective wisdom of a broadly constituted group of experts
(professionals and consumers) is a key ﬁrst step in deﬁning
a list of potential research options. The high degree of
commitment required by the repeated rounds of a Delphi
process (McKnight et al. 1991) may preclude the involve-
ment of some participants such as patients undergoing
treatment. A modiﬁed process that limits the role of the
Delphi group to constructing a list of strategies without
rating their relative importance has the capacity to reduce
participant response costs and time required. The second
step in the value-weighting process involves a resource
allocation (value-weighting) exercise in the form of a
survey with the wider expert population. This second step
allows a large number of participants to anonymously
indicate the relative perceived value of each item in a
timely manner. Underpinning the resource allocation
exercise is the recognition that a complex interplay of
factors must be distilled into single decisions when
making strategic plans for research. These complex con-
siderations must then be applied in the context of a
limited funding base. This method mimics the decisions
often faced by those who need to allocate resources for
research or programme delivery. By requiring a range of
participants to frame their decision in terms similar to
that faced by the funding agency itself, the direct rel-
evance and potential usefulness of the data is increased.
The views of participants can be either aggregated to
obtain an overall view or separated by participant group to
explore whether, e.g. clinicians and patients differ in their
perceived priorities for research. Therefore, the value-
weighting method is a time-efﬁcient way to open up
opportunities for increased breadth and depth of partici-
pation, potentially increasing the likelihood that funding
agencies will take a structured approach to allocating
research priorities.
Aims
This study will explore the perceived psychosocial
research priorities for older adults (aged 30 years or older)
with haematological cancers from the perspective of
health professionals, patients and partners/carers. Partici-
pant perceptions regarding the relative beneﬁt associated
with research efforts will be analysed in light of:
1 Research populations: e.g. patients undergoing treat-
ment, patients who have relapsed or carers.
2 Psychosocial research: e.g. describing which patients
are at high risk of poor psychosocial outcomes versus
testing the effectiveness of particular forms of therapy
or support.
3 Respondent groups: e.g. comparing the priorities of each
respondent group to determine whether there are differ-
ences in views about research priorities.
METHODS
A two-stage value-weighting process was used, ﬁrst to
identify the range of potential options for psychosocial
research, how these might be presented in a survey format
(stage I) and then to quantify the potentially different
views of a varied group of health professionals, patients
and carers on this topic (stage II).
Methodological strengths
The strengths of the current methodology arise from both
the sampling method and the modiﬁed Delphi approach
used to construct the survey. Although the current sample
was made of both self-selecting and convenient samples, it
encompasses a broad group of stakeholders who are likely
to be most affected by research funding allocation. While
clinicians are often over-represented in comparison with
patients in decision-making processes (Oliver et al. 2004),
the value-weighting approach facilitates the involvement
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consumers. The inclusion of a value-weighting survey has
the ﬂexibility to determine whether and where there is
consensus in a timely manner.
Stage I
A national advisory group consisting of leading research-
ers, healthcare professionals and patient representatives in
the areas of blood cancer and psychosocial outcomes was
formed under the auspices of the Leukaemia Foundation
of Australia (The Foundation). The Foundation nominated
13 individuals to represent a variety of stakeholders and
viewpoints including consumers, clinicians, providers of
psychosocial care, researchers and those involved in pro-
gramme management and advocacy. In-principle deﬁni-
tions of expertise were used including peer recognition
and previous involvement in consumer-led activities (con-
sumers), number of years of experience (clinicians and
programme managers), research track record (researchers)
and degree of patient contact (providers of psychosocial
care). The advisory group were involved in three rounds of
a modiﬁed Delphi via teleconferences and email commu-
nications to develop a list of potential priority areas for
psychosocial research in conjunction with the authors.
The task of the group was to achieve consensus regarding
the range of research topics to be included in the web
survey. The multiple rounds permitted a reduction on the
complexity and number of potential items presented to
participants in the web-based survey.
The outputs of stage I were:
￿ A list and deﬁnitions of population groups/steps in the
cancer journey.
￿ A list and deﬁnitions of types of psychosocial research.
￿ Question stems and response scales for the web survey
(described in stage II below).
Stage II
Sample
The advisory group nominated the names of Australian
experts in their ﬁeld to form the survey sample. This
included clinicians, researchers, psychosocial care provid-
ers such as psychologists or social workers, and those
involved in programme development or delivery in the
area of psychosocial care. This group is described as
‘health professionals’ for brevity from here onwards.
The Foundation promoted the survey via its regular
newsletter to patients and carers. Patients could include
those at any stage of care. Carers could include any part-
ners, family members or friends who had provided any
form of care to a patient with haematological cancer.
Those interested in completing the survey and with Inter-
net access responded by email to the researchers.
Procedure
All potential web survey participants (health profession-
als, patients and carers) were provided with a unique web
link to the survey in November 2008. Up to two email
reminders were provided to those who had indicated their
interest and did not complete the survey within 4 weeks
of the initial email.
Web-based survey
The survey provided a value-weighting scenario to allo-
cate token funding to different areas of psychosocial
research to show which research should be given priority:
‘Imagine that the Leukaemia Foundation has asked you to
decide which areas of psychosocial research should be
funded. How would you allocate funding among these
research areas so that they have the greatest impact on
psychosocial outcomes for older adults diagnosed with
blood cancer and their families? You can allocate all the
funding to one area, or allocate different amounts of
funding to different areas.’
Research populations
Each participant was asked to allocate 100 points of
‘funding’ across the following research populations/cancer
stages:
￿ Patients newly diagnosed or in treatment.
￿ Patients ﬁnished initial treatment or receiving mainte-
nance treatment.
￿ Patients who have relapsed.
￿ Patients receiving palliative care.
￿ Partners and carers.
￿ Other family or friends.
Psychosocial research
Participants then allocated another 100 points of funding
across the following types of psychosocial research:
￿ Developing measures to identify psychosocial
concerns.
￿ Identifying who is at risk of poor psychosocial health
and who is resilient.
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education for all.
￿ Evaluating the effectiveness of physical or psychologi-
cal therapies for those who need it.
￿ Testing the beneﬁt of improving social, community
and spiritual support options.
￿ Testing the beneﬁt of improvements in treatment
centres or care delivery.
￿ Incorporating research into practice.
Each survey item was presented with an ‘i’ icon that
allowed the respondent to view the more detailed deﬁni-
tions for each item.
Respondent groups
Participants also completed items on demographic char-
acteristics (age, gender), and where relevant: disease char-
acteristics (disease type, time since diagnosis, stage of
care, treatment received), carer/support person details
(disease characteristics of person cared for) or professional
background (ﬁeld of speciality and primary role, research
position and areas of research).
Analysis
Data collected from the web-based survey was analysed in
STATA (Boston & Sumner 2003) using descriptive statis-
tics. Histograms and frequency distributions revealed
that: distribution of funding allocation was normal or
near-normal for all response categories. Therefore, the
mean allocation was used to rank the perceived impor-
tance of the research populations and types. The means
and 95% conﬁdence intervals for each research population
and psychosocial research type were calculated and
plotted against a line representing non-preferential
funding allocation. Two-tailed non-parametric tests
(Kruskall–Wallis) were used to assess whether the respon-
dent groups differed from each other in their mean
research allocations for each item, using an alpha level of
0.05.
The University of Newcastle Human Research Ethics
Committee provided ethical approval for this study. Par-
ticipants provided their implied informed consent by com-
pleting the survey.
RESULTS
Survey sample
A total of 191 potential participants were identiﬁed and a
total of 117 web surveys were completed (an overall
response rate of 61%), with 41 participants describing
themselves as health professionals (4 clinicians, 23 nurses,
11 allied health workers, 3 other), 45 as patients (26 were
diagnosed with leukaemia, 6 with multiple myeloma, 10
with lymphoma and 7 with other forms of blood cancer)
and 31 indicating they were carers. The majority of
patients had received their diagnosis more than 1 year
prior to completing the survey (n = 42, 93%). Over 50% of
patients reported being ﬁnished treatment and having
check-ups (n = 23, 51.1%). Only six patients were cur-
rently in the curative treatment stage (13.3%), with none
reporting being in palliative care. Health professionals
were of an average age of 40.9 years old, survivors 57.3
years and carers 55.9 years. The proportion of women in
each group was 47% for health professionals, 90% for
survivors and 65% for carers.
Perceived priorities for research populations
The overall perceived importance of research with each
population group in terms of improving psychosocial out-
comes for blood cancer patients aged 30 years and older is
described in Table 1. Mean research allocation is pre-
sented in rank order from highest proportional allocation
to lowest allocation. The mean allocation to each research
population varied from the highest perceived priority
(29% of research allocation) for patients newly diagnosed
or in treatment, down to the lowest priority being family
and friends other than partners or carers (4.8% of research
allocation).
Plotting the mean research allocations and 95%
conﬁdence intervals against a line representing non-
preferential funding allocation (i.e. allocating 16.67 points
to each of the six research populations) provides an indi-
cation of the variability among individuals’ research allo-
cations (conﬁdence intervals) and whether the allocations
appear to be signiﬁcantly different from each other. As
shown in Figure 1, all participant groups gave signiﬁcantly
higher priority to psychosocial research directed towards
patients who are newly diagnosed or in the active phases
of treatment. Psychosocial research relating to other
family and friends was seen as a signiﬁcantly lower prior-
ity than any of the other populations.
Perceived priorities for psychosocial research
The overall perceived importance of each type of psycho-
social research is described in Table 1. The mean alloca-
tion to each research type varied from the highest
perceived priority being the development of measures to
identify psychosocial concerns (15% of allocation), down
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improving social, community and spiritual support
options (11% of research allocation). As shown in
Figure 2, the overall allocations to research types
were generally not signiﬁcantly different from non-
preferential allocation (i.e. allocating 14.28 points to
each of the seven options).
Agreement between respondent groups
In the case of research populations, a similar pattern of
preferences appeared for each respondent group (see
Table 1). The Kruskall–Wallis test indicated that there
were signiﬁcant differences in mean allocation by partici-
pant group only in terms of provider allocations to the
Table 1. Mean proportion and rank for research allocated for research population and type of psychosocial research
Mean research allocation (%)
Overall
rank (n)
Healthcare
professionals (n = 41)
Patients
(n = 45)
Carers
(n = 31)
All
(n = 117)
Research population
Patients newly diagnosed or in treatment 25.4 30.7 30.3 28.8 1
Patients who have relapsed 23.5 21.9 18.1 21.5 2
Patients ﬁnished initial treatment or in maintenance treatment 20.9 16.7 17.2 18.3 3
Partners and carers 14.8 13.2 14.0 14.3 4
Patients receiving palliative care 10.0 13.6 15.0 12.4 5
Other family and friends 5.3 3.8 5.5 4.8 6
Type of psychosocial research
Develop measures to identify psychosocial concerns 12.9 17.1 16.1 15.4 1
Evaluate effectiveness of physical or psychological therapies for
those who need it
20.0 15.9 12.9 16.6 2
Test the beneﬁt of improving treatment centres or care delivery 15.4 15.3 17.7 16.0 3
Identify who is at risk of poor psychosocial health and who is
resilient
14.3 17.8 12.1 15.1 4
Incorporating existing research into practice 13.6 13.4 15.3 14.0 5
Testing the beneﬁt of providing better information and education
for all
12.8 10.5 14.2 12.3 6
Testing the beneﬁt of improving social, community and spiritual
support options
11.1 9.9 11.6 10.8 7
Figure 1. Allocations to research populations according to par-
ticipant group. Labels: 1.1 = newly diagnosed patients, 1.2 =
patients in maintenance, 1.3 = patients in relapse, 1.4 = patients
in palliative care, 1.5 = partners and carers, 1.6 = other family and
friends. () provider; ( ) carer; () patient.
Figure 2. Allocations to psychosocial research areas according to
participant group. Labels: 2.1 = develop measures, 2.2 = identify-
ing who is at risk, 2.3 = test education, 2.4 = evaluate psychologi-
cal therapies, 2.5 = test social and community support, 2.6 =
treatment centre, 2.7 = research into practice. () provider; ( )
carer; () patient.
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were the allocations of carers (P = 0.02).
In the case of psychosocial research types, patient allo-
cations to the identiﬁcation of those at risk of poor psy-
chosocial health were signiﬁcantly higher than were carer
allocations to this type of research (P = 0.04). The differ-
ence between carer and provider allocations to evaluate
the effectiveness of physical or psychological therapies
was also signiﬁcant (P = 0.02), with healthcare providers
providing a greater allocation than partners/carers.
DISCUSSION
Perceived priorities regarding research populations
For all participants combined, greater psychosocial
research priority was apportioned to patient populations
in the earlier stages of haematological cancer – being
newly diagnosed or in treatment. It should be noted that
while relatively small allocations (approximately 14%)
were directed towards partners/carers and patients receiv-
ing palliative care; these areas were still considered
worthy of research, albeit with lower priority. It may be
worth exploring why a relatively low perceived priority
was evident for research into palliative care, given that
need for psychosocial support may be high in this phase. It
is possible that the sample does not contain enough par-
ticipants with a need for or expertise in palliative care to
fully represent this aspect of the cancer journey. Despite
the low perceived priority for research on this topic, the
little available research does not suggest that palliative
care for haematological cancers operates at an optimal
level (McGrath 2002).
The results present a reasonably clear case for strategic
allocation of research resources to those who are newly
diagnosed or receiving treatment. These ﬁndings appear to
be in contrast to the ethical constraints often faced by
researchers, where gatekeepers such as clinicians or ethics
committees prohibit research access to patients in these
vulnerable stages. Research protocols that facilitate sen-
sitive approaches to such patients and allow for research
rigour may be necessary.
Perceived priorities regarding psychosocial
research types
Study participants did not appear to have a strong prefer-
ence for one type of research over another, with one excep-
tion: in the case of the provider participant group, there
appeared to be a preference for evaluating the effectiveness
of physical or psychological therapies for those who need
it (20% of research allocation). This may indicate that
healthcare professionals, who are in the position of pro-
viding referrals for distressed patients or directly providing
psychosocial care, may feel there is a need for more data in
order to provide evidence-based care. Reviews of the lit-
erature support the need for more rigorous evidence on the
effectiveness of interventions for psychosocial health in
cancer patients (Trivedi et al. 2007; Boesen & Johansen
2008; Ranmal et al. 2008; Goedendorp et al. 2009).
There are a number of potential interpretations of the
apparent overall lack of discrimination regarding priorities
across the different types of research. First, it may be that
there is an evident need for research in all of these areas,
and each is perceived to have similar potential for improv-
ing psychosocial outcomes for people with haematological
cancers. Second, it may be that the participants did not
feel well-informed about the range of research types they
were asked to consider. Third, the level of complexity
involved in comparing quite different types of research
(e.g. the development of measures versus testing the
beneﬁt of improved treatment centres) limited partici-
pants’ ability to differentiate between items. In the
absence of a more in-depth examination of reasons for
these allocations, the data presented here suggest that
funding should be directed towards a range of types of
psychosocial research interventions for haematological
cancer patients.
Agreement between respondent groups
The allocations provided by each of the participant groups
suggests that in general terms there was compatibility in
the preferences expressed by health professionals, patients
and carers. There was a strong correspondence in the rela-
tive rankings for both research populations and types of
research even though each subgroup gave slightly differing
weights or allocations in some instances. This may reﬂect
a general need for research in this ﬁeld. Providers gave a
higher priority to patients experiencing relapse and to
evaluating psychological therapies than non-provider
groups, while patients placed a greater emphasis on the
identiﬁcation of patients at risk of experiencing psycho-
social morbidity. This may be because patients feel that
psychosocial problems are not readily identiﬁed by the
health system. This is not surprising, given the data sug-
gesting that clinicians are not always good at identifying
patients who are experiencing psychosocial problems
(Trivedi et al. 2007). However, the relative consistency of
results across groups suggests that the growing impetus
for consumer involvement in research planning (Oliver
et al. 2004) is not likely to be problematic and that a range
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priorities.
Study methodology and limitations
The study sample method was one of both convenience
and self-selection. Sampling using a convenience method
may result in a sample that does not accurately reﬂect the
prevalence of groups in the wider population. However,
strong representation from key professional groups and
consumer groups was obtained. Having consumer partici-
pants volunteer to complete the survey may have resulted
in a selection bias. Sampling bias where participants have
any control over whether to participate is usually assumed
to result in a polarisation of opinion, as the individuals
who self-select into an opinion-based study are likely to
have stronger opinions, and therefore be more motivated
to participate (Pagano 1992). Given the normal distribu-
tion of scores in most instances, it was concluded that this
was not the case in the current study. Therefore, the
self-selection of patients and carers into the study is
unlikely to impact the overall conclusion of the study.
The high proportion of women in the patient group sug-
gests that the patient preferences described here may not
adequately represent the views of male patients. Combin-
ing patients at various stages of care and support people
groups into one weighting exercise for the research popu-
lation question may have been challenging for partici-
pants. While this may have been difﬁcult for the
respondents, it does reﬂect the sorts of decisions that need
to be made during strategic allocation of funding. A
further limitation is that the reliability and validity of the
scale are yet to be tested.
A further limitation that exists in the current sample
relates to the lack of participants who have experienced
palliative care. This means that research into psychosocial
issues underlying this stage of care may have received
lower priority weightings, which was certainly the case.
Recent research has determined that fewer patients with
haematological malignancies were involved with pallia-
tive compared with patients with colorectal cancer, and
that more patients die in the acute care setting (Maddocks
et al. 1994). A recent survey of Australian haematologists
revealed that respondents did not refer patients to
palliative care for a variety of reasons, which included
wishing to remain optimistic, the lack of experience of
palliative care services in managing haematological
cancer patients and the difﬁculty in deﬁning patients from
this group as terminal (Auret et al. 2003). The lack of
experience with palliative care within this patient popu-
lation, and the quick deterioration that often occurs
between curative treatment and death, may account for
the lack of patients in the current sample who have expe-
rienced this form of care. This may in turn explain the
lower priority given to examining psychosocial issues in
this stage. Further research will need to address the lower
referral of this patient group to palliative care, before psy-
chosocial issues can be examined.
CONCLUSIONS
The data suggest that a substantial proportion of psycho-
social research resources for haematological cancer
patients should be directed towards patients who are
newly diagnosed or receiving treatment rather than later
stages of the cancer journey. While there appeared to be no
strong preference for prioritisation of particular types of
psychosocial research, this may reﬂect the general need
for greater research into the range of potential interven-
tions to improve psychosocial outcomes for patients with
haematological cancers. The views of various stakehold-
ers are often compatible although not identical.
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